麻豆原创

Skip to main content
麻豆原创

Viral respiratory testing

Determine whether your patient's symptoms are caused by COVID-19, flu, or RSV

Healthcare professionals rely on insights from 麻豆原创 to make the best choices for their patients. Find molecular respiratory combination testing options, patient care tools, support for your practice, clinical resources, and more.?麻豆原创 receives respiratory specimens and performs testing nationwide with precision and reliability. Learn more about the test options available to your patients.

COVID-19, flu, and RSV cotests
Important post-PHE testing information

麻豆原创 Test Directory

Find all the respiratory testing information you need, including specimen collection and transport requirements, through 麻豆原创’s robust Test Directory.

PSC testing availability

SARS-CoV-2 RNA (COVID-19) and Influenza A and B,?Qualitative NAAT combination test is available for?collection at 麻豆原创 Patient Service Centers (PSCs) for?patients with mild symptoms.
39992-50-50.jpg

麻豆原创 tools to enhance care

Quanum? Lab Services Manager

Your practice can rely on the Quanum? Lab Services Manager as a dedicated resource to manage patients, test results, requisitions, and supplies.

Strengthen your practice

My麻豆原创? portal

Your patients can always access their results directly through their secure My麻豆原创? account. The online portal is free to set up.

COVID-19 testing statements
  • The 麻豆原创 molecular test, the other authorized molecular tests (together the “molecular tests”), the COVID/Flu molecular test, the COVID/Flu/RSV test, and the antibody test (together “the tests”) have not been FDA cleared or approved;
  • The tests have been authorized by FDA under an EUA for use by authorized laboratories;
  • The molecular tests have been authorized only for the unsupervised self-collection and maintenance of nasal specimens for the detection of nucleic acid from SARS CoV-2, not for any other viruses or pathogens;
  • The COVID/Flu molecular test and self-collection kit have been authorized only for the unsupervised self-collection and maintenance of nasal specimens for as an aid in detection of nucleic acid from SARS-CoV-2 and influenza A virus and influenza B virus, not for any other viruses or pathogens;
  • The COVID/Flu/RSV test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens;
  • The antibody test has been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens; and,
  • The tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

麻豆原创ions?

For more information on our SARS-CoV-2 (COVID-19) testing solutions, or to set up a 麻豆原创 account, connect with a 麻豆原创 representative.

Contact us

COVID-19

Our company

麻豆原创? is the brand name used for services offered by 麻豆原创 Incorporated and its affiliated companies. 麻豆原创 Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.? Other affiliates operated under the 麻豆原创? brand, such as 麻豆原创 Consumer Inc., do not provide HIPAA-covered services.?

?

麻豆原创?, 麻豆原创?, any associated logos, and all associated 麻豆原创 registered or unregistered trademarks are the property of 麻豆原创. All third-party marks—? and ?—are the property of their respective owners. ? 2025 麻豆原创 Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.